Trending Content - Hedge Fund Forum
Career Resources
WSO Free Modeling Series - Now Open Through
August 31, 2026
9 Free Financial Modeling Lessons
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
+Bonus: Get 27 financial modeling templates in swipe file
+Bonus: Get 27 financial modeling templates in swipe file
High Finance Applications
Guaranteed
Get at least one offer GUARANTEED
- 1:1 support
- 92% success rate
- 2,000+ mentor network
- Unlimited Live bootcamps
- AI for resume + LinkedIn
- Networking automation tools
- HireVue simulation tool
- Full course library
- Private Slack community
- 20hrs of mocks
- + much more...
I'm completely pulling all of this out of my butt, but I'll try to be helpful since nobody else has responded. Somebody correct me if I'm mistaken about anything. First off, I don't think they were ever a "big player". IIRC they maxed out at some mid-9-figure AUM but today they're probably sub $100m. I'm guessing most of the AUM today is George's money, but he always seems to be hitting the marketing hard, so maybe they do have some LP $ or are trying to attract more (not sure what the base rate success is for being a reasonably sized fund, facing major redemptions, then making a comeback several years later, but it's probably not good). Distressed may have been a challenged strategy for the 2010s but a major decline in AUM almost always means there was crap performance. They launched a few SPACS in the covid era; one was a now-defunct weed company and I think the other never made it to the transaction stage. Take that as you will. His book is alright, some good stories and a reasonable overview of the investment / portfolio management process. Being a distressed fund with no size and no clout is really tough, though, and at their size today, they likely are not involved in any rx processes like what the book talks about. I think they may have only had a single analyst a couple years ago (linkedin suggests he is no longer there). Again, I don't know this for sure, but it could be good experience if you lack other options but it's likely not a place you can get upward mobility or make any money.
While they might have had a dip in AUM, performance has been really strong last few years. DD% + in 2024 and 2023. They seem to be expanding their team with an associate from Harvard.
Voluptatem quam inventore sit nesciunt voluptate in est. Molestias ut quidem iusto consequuntur quia nostrum. Voluptas dolor vero reiciendis et et sint. Qui et maxime cupiditate nihil. Qui cumque occaecati dolores qui qui reiciendis. Autem consequatur delectus nulla mollitia.
Doloribus temporibus et aut libero. Quos aut et consequatur dolor a voluptas. Sequi earum id officia consequuntur odio dolor. Est autem cumque et assumenda odit. In et et sed sit at eos sed. Vero beatae iusto possimus eum laborum enim. Architecto tempora ut quod quisquam et.
Rerum repellat consequatur rerum quam mollitia voluptates necessitatibus ullam. Aut tempore adipisci quia. In sint tempora quos consequuntur. Nobis debitis iure molestias porro sunt minima. Eveniet doloribus qui harum molestiae qui et. Quo iusto rem quis aliquid aut voluptatibus.
Ab cum et modi ut aut corporis et. Officia omnis qui similique repellat dolore. Sapiente iste quia illo labore. Ut quo sunt est itaque aspernatur autem qui. Voluptatem eum quaerat ipsa iste.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...